{"name":"Kangpu Biopharmaceuticals, Ltd.","slug":"kangpu-biopharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPZWJueVpKWXNhWmtQTlJzRHlISGJZZGc0SndJR0lSRWUyNzRXT0FnclJwMTNtNkdncFJGazBLaGhfSE9vUHZJUkdDSFRZMG9CQ2w1YnJWOG5KTTFTc19KQWc1WWs0RTRPODY2TUZnSzdmLW5JSzlzVnZxMk9xeEtpVlIzaG5FNkZKTzZKTzN1TzRWVjY4amhmXzNYdENKR19wMk01UFU4NWdjS1VOMlpDZTcxVUJLSjYtV3pXb254RmlWVDctVnpJVk1IakpYb19aTWpIZnNScHhkZVM2SzRkRmt1YkdWTUJZWnloLTIta2VFTUZoNHJ5Ug?oc=5","date":"2025-08-13","type":"pipeline","source":"PR Newswire","summary":"GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight - PR Newswire","headline":"GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVXR3X1llcjZvcTktdnduWjhoZ1NRMUpCVGs4Qy14cXljSm92MUVTajNnX2g1S0ZwbjZJVFNaTWRtNTVMUG9lNW56cnZoMm54a190eklkak9hT2ZpWDVDeUJzRU91Z3otSXFEY1Nub0VrQ1BZZ2p5UmwzSGtxQldQb3p2Q1gwUmszSDFkdnJOYUdESUZPZ21aOHpqa3lVS05vVF81Wk01OE1XSUpqRmhjMDJId1JoVHFUS0ZNT05aWl85RVAzcnRNU1hXRTM2VWRqWlZtNE1BY1V6b2F5a2N3WGs2STFvNUxlalBv?oc=5","date":"2025-08-07","type":"pipeline","source":"PR Newswire UK","summary":"FAP Inhibitors Market Analysis Across the 7MM: Key Insights and Outlook Through 2040 | DelveInsight - PR Newswire UK","headline":"FAP Inhibitors Market Analysis Across the 7MM: Key Insights and Outlook Through 2040 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQYW5xbUplaGxlZVNLeHl2UDdNVDNGYXMtb3AwNlpqVTg0RllFOUI0dC00T1JtZl9hcEFKTTAyT1F5MEstNGhJSzltUzk5X1JBaGxBVFVTeTF6MjBfLS1rT3Fub2I0MG9SZ0lieXB1ZktLYlo0OGk1XzZiT0M4MTFOeFh2MU5NQlJBTXlNOF9CZUM0ZjlueFowNjgtSC15bmtWaHkyUkN2MEN4cnJoOHlEV0RXbGxXTVF0X0FKNXYyanFmTTQ4MjRUWXJlMEI2LTVZRnNRSEkyZFdNRnMzTXNQYjRJb3h0N3c1TFNn?oc=5","date":"2025-02-26","type":"regulatory","source":"BioSpace","summary":"Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma - BioSpace","headline":"Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-02-17","type":"pipeline","source":"globenewswire.com","summary":"Metastatic Castration-Resistant Prostate Cancer Market to - globenewswire.com","headline":"Metastatic Castration-Resistant Prostate Cancer Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNYWZIR1FURDU4dFFXaEs3bjFkYk4zOERRa25WempmaDRMcndkNEtQTV81NTlUWWdONjNxLVdrNmlfMHBRZVU1a055NlhFLTVQcEs0LTNFWktRZDR1RHVtVjRIMzBuMVZuUFhDa01WT3lKaTY4ckZQRjFlSnc2YzNjTjhRbU5yYjN3NC1pSU1ZYTM3b1pVRjhyVVRxMGxRbFpmcUtoQ0VDTlY3VTJySExPM0t3a1JhU3pWUGROWV9yTmNHLXZ4UUZybzdDYS05R3lwRFozaGJHTkNFVjRTV0dfb2U5VDNEODhBaDdNTmJNNl9FUzJKT29ZV016Ynk0VTZjdjQ2S3NDV3paeVpWNDFUN2IzaFpKd0RZc21mSlZwTXhxeUVnNTRuQ0hQQ0pGamZTT1M5ZjNXZ1lGdU0zbzcteXdUWQ?oc=5","date":"2024-10-15","type":"trial","source":"globenewswire.com","summary":"Prostate Cancer Clinical Trial Pipeline Experiences - globenewswire.com","headline":"Prostate Cancer Clinical Trial Pipeline Experiences","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}